OTC · Medical - Pharmaceuticals

Lotus Pharmaceuticals, Inc. (LTUS) Stock

$0.00 OTC: LTUS Healthcare

Lotus Pharmaceuticals, Inc. currently has no substantial business activities.

Valuation

MetricValue
Price$0.00
Market Cap$108376
P/E Ratio-309.34
P/B Ratio0.00
P/S Ratio0.15
EPS (TTM)$-0.02
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE1.82%
ROA4.56%
ROCE0.00%
Gross Margin35.64%
Operating Margin6.66%
Net Margin2.43%
Debt/Equity0.06
Current Ratio0.53

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$0——
Total Liabilities$0$0$0——
Cash$0$0$0——
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0——
Investing Cash Flow$0$0$0——
Financing Cash Flow$0$0$0——
Net Cash Flow$0$0$0——
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-3.09
EV / EBITDA-3.21
FCF Yield0.00%
Quick Ratio0.00
Interest Coverage0.00
Return 1Y-53.53%
Return 3Y-28.18%
Return 5Y-88.52%

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPTAll American Pet Company, Inc. $0.00 — -0.02 $172870 0.00%
ALDAAtlantica, Inc. $0.05 +0.00% -0.28 $122930 0.00%
AWONA1 Group, Inc. $0.00 — -12.50 $85587 0.00%
AWWIAlpha Wastewater, Inc. $0.00 — -0.18 $94641 0.00%
CDSGChina Dongsheng International, Inc. $0.00 — 3.80 $59937 0.00%

About Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.

Lotus Pharmaceuticals, Inc. (LTUS) stock trades at $0.00 with a market capitalization of $108376. The stock is valued at a price-to-earnings (P/E) ratio of -309.34, price-to-book of 0.00, price-to-sales of 0.15. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, Lotus Pharmaceuticals, Inc. generates a return on equity (ROE) of 1.82%, return on capital employed of 0.00%, an operating margin of 6.66%, a net profit margin of 2.43%.

Official website: lotuspharmaceuticalsusa.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides